Xiaodong Wang - 11 Jun 2026 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Reporting relationship: Director, Chair, Scientific Advisory Brd
Issuer ticker: ONC
Reported as of: 11 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2026, 17:54:54 UTC
Prior SEC filing: 12 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Qing Nian, as Attorney-in-Fact

Key filing fact

Xiaodong Wang filed Form 4 for BeOne Medicines Ltd. (ONC) on 15 Jun 2026.

Key facts

This page summarizes Xiaodong Wang's Form 4 filing for BeOne Medicines Ltd. (ONC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2026, 17:54.

Change

Previous filing in this sequence was filed on 12 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001662982 Primary reporting owner

Wang Xiaodong

Relationship: Director, Chair, Scientific Advisory Brd
Address: C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND
Signature: /s/ Qing Nian, as Attorney-in-Fact
Signature date: 15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ONC transaction

Ordinary Shares

Award

Transaction value
Shares: +99,892
Change %: +2.2%
Price: $0.000000^*
Shares after: 4,682,493
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,025,063
Date: 11 Jun 2026
Ownership: See Footnote
Footnotes: F2

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,953,100
Date: 11 Jun 2026
Ownership: See Footnote
Footnotes: F3

ONC holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 50
Date: 11 Jun 2026
Ownership: See Footnote
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ONC transaction Derivative

Share Option (Right to Buy)

Award

Transaction value
Shares: +193,492
Change %
Price: $0.000000^*
Shares after: 193,492
Date: 11 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 193,492
Exercise price: $20.81
Footnotes: F5, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Footnote F2

These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.

Footnote F3

These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.

Footnote F4

These securities are held by the spouse of the Reporting Person.

Footnote F5

The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares.

Footnote F6

These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.